Benzinga | May 11, 2021 04:28PM EDT

Verastem Oncology Q1 Adj. EPS $(0.07) Up From $(0.20) YoY, Sales $1.00M Down From $5.06M YoY

Verastem Oncology (NASDAQ:VSTM) reported quarterly losses of $(0.07) per share. This is a 65 percent increase over losses of $(0.20) per share from the same period last year. The company reported $1.00 million in sales this quarter. This is a 80.22 percent decrease over sales of $5.06 million the same period last year.